Your email has been successfully added to our mailing list.

×
0 0 0 0 0.0139160839160839 0.00699300699300716 0.0139860139860142 0.0134965034965036
Stock impact report

9 Meters Announces Initiation of Phase 2 VIBRANT Study of Vurolenatide for Short Bowel Syndrome

9 Meters Biopharma, Inc. (NMTR) 
Company Research Source: Accesswire
Initiating the largest Phase 2 placebo-controlled trial in short bowel syndromeTopline results of the multicenter VIBRANT study anticipated in Q4 2021RALEIGH, NC / ACCESSWIRE / June 14, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage biotechnology company focused on rare and unmet needs in gastroenterology, announced today the initiation of its Phase 2 trial of vurolenatide, a proprietary long-acting glucagon-like peptide-1 (GLP-1) agonist in adults with short bowel syndrome (SBS)."Initiating our Phase 2 trial of vurolenatide marks an important milestone for patients and families impacted by the debilitating effects of short bowel syndrome, including chronic diarrhea," said John Temperato, President and Chief Executive Officer of 9 Meters. "This pushes us one step closer to potentially offering patients a treatment option that's long-acting with rapid onset and potentially fewer safety concerns than currently available therapeutics."The Phase 2 trial, known as the VIBR Show less Read more
Impact Snapshot
Event Time:
NMTR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for NMTR alerts
Opt-in for
NMTR alerts

from News Quantified
Opt-in for
NMTR alerts

from News Quantified